Enzymatica AB (publ): management transactions · Finland · FIN-FSA FI:enzymatica-ab-publ SE0003943620 FI FI · FIN-FSA Mcap 602M€ Healthcare
Browse the full insider trade history of Enzymatica AB (publ), a listed issuer based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Enzymatica AB (publ) has published 6 insider filings. Market capitalisation: €602m. The latest transaction was disclosed on 1 April 2026 — Sale. Among the most active insiders: Anna Söderlund. All data is free.
Financial data FY ended December 2025 · cache
Income statement
Revenue 53.9 M€
Gross profit 33.1 M€ 61% margin
Net income −51.9 M€ -89.2% margin
Balance sheet & cash
Market cap 602.0 M€
Total debt 1.0 M€
Free Cash Flow −41.2 M€
Debt / Equity 1%
Profitability & ownership
ROE -35.2%
ROA -19.0%
% insiders 69.4%
% institutions 4.3%
Last declaration on 1 April 2026
Declarations 6 total
Executives ● Sale20 FIN-FSA
€10,959 40,000 shares @ €0.274 0.0018% mcap 32.1% of flow SE0003943620⌘
Aktie
FI:A003X482-1 · 31 Mar 2026
Executives ● Purchase14 FIN-FSA
€13,523 48,000 shares @ €0.2817 0.0022% mcap 36.0% of flow SE0003943620⌘
Aktie
FI:A003M475-1 · 12 Mar 2025
Ideal exit: 7 Dec 2025 (T+270) Executives ● Purchase18 FIN-FSA
€12,806 50,000 shares @ €0.2561 0.0021% mcap 37.5% of flow SE0003943620⌘
Aktie
FI:A003M472-1 · 12 Mar 2025
Ideal exit: 7 Dec 2025 (T+270) Executives ● Purchase17 FIN-FSA
€10,396 40,000 shares @ €0.2599 0.0017% mcap 30.4% of flow SE0003943620⌘
Aktie
FI:A003M250-1 · 6 Mar 2025
Ideal exit: 1 Dec 2025 (T+270) Executives ● Purchase18 FIN-FSA
€922 3,500 shares @ €0.2635 0.0002% mcap 100.0% of flow SE0003943620⌘
Aktie
FI:A003M244-1 · 6 Mar 2025
Ideal exit: 1 Dec 2025 (T+270) Executives ● Purchase16 FIN-FSA
€24,040 100,000 shares @ €0.2404 0.0040% mcap 64.0% of flow SE0003943620⌘
Aktie
FI:A003M153-1 · 3 Mar 2025
Ideal exit: 28 Nov 2025 (T+270)